OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered celastrol and plasmid co-delivery for in situ expression and targeted mitochondrial relocation of Nur77 protein towards effective drug resistance reversion
Minting Liu, Zheng Luo, Zhiguo Li, et al.
Chemical Engineering Journal (2022) Vol. 453, pp. 139879-139879
Closed Access | Times Cited: 13
Minting Liu, Zheng Luo, Zhiguo Li, et al.
Chemical Engineering Journal (2022) Vol. 453, pp. 139879-139879
Closed Access | Times Cited: 13
Showing 13 citing articles:
Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy
Liuzhou Mao, Panqin Ma, Xi Luo, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9826-9849
Closed Access | Times Cited: 32
Liuzhou Mao, Panqin Ma, Xi Luo, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9826-9849
Closed Access | Times Cited: 32
Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 15
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 15
Logic “AND Gate Circuit”-Based Gasdermin Protein Expressing Nanoplatform Induces Tumor-Specific Pyroptosis to Enhance Cancer Immunotherapy
Xiaoxi Wang, Wen‐Yan Zhang, Yan Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6946-6962
Closed Access | Times Cited: 5
Xiaoxi Wang, Wen‐Yan Zhang, Yan Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6946-6962
Closed Access | Times Cited: 5
Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR/Cas9 gene editing system delivery
Panqin Ma, Qi Wang, Xi Luo, et al.
Biomaterials Science (2023) Vol. 11, Iss. 15, pp. 5078-5094
Closed Access | Times Cited: 12
Panqin Ma, Qi Wang, Xi Luo, et al.
Biomaterials Science (2023) Vol. 11, Iss. 15, pp. 5078-5094
Closed Access | Times Cited: 12
Mitochondrial Artificial K+ Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis
Panqin Ma, Zheng Luo, Zhiguo Li, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 9
Panqin Ma, Zheng Luo, Zhiguo Li, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 9
Enhancement efficiency delivery of antiviral Molnupiravir-drug via the loading with self-assembly nanoparticles of pycnogenol and cellulose which are decorated by zinc oxide nanoparticles for COVID-19 therapy
Nagi M. El‐Shafai, Yasser S. Mostafa, Mohamed S. Ramadan, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107028-107028
Closed Access | Times Cited: 9
Nagi M. El‐Shafai, Yasser S. Mostafa, Mohamed S. Ramadan, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107028-107028
Closed Access | Times Cited: 9
Revolutionizing cellular energy: The convergence of mitochondrial dynamics and delivery technologies
Dilpreet Singh
Mitochondrion (2024) Vol. 76, pp. 101873-101873
Closed Access | Times Cited: 1
Dilpreet Singh
Mitochondrion (2024) Vol. 76, pp. 101873-101873
Closed Access | Times Cited: 1
A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance
Penghui Wang, Yuling Wang, Xuelin Xia, et al.
Nanoscale (2024) Vol. 16, Iss. 17, pp. 8434-8446
Closed Access | Times Cited: 1
Penghui Wang, Yuling Wang, Xuelin Xia, et al.
Nanoscale (2024) Vol. 16, Iss. 17, pp. 8434-8446
Closed Access | Times Cited: 1
Combined activation of artificial and natural ion channels for disrupting mitochondrial ion homeostasis towards effective postoperative tumor recurrence and metastasis suppression
Panqin Ma, Zheng Luo, Qi Wang, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3282-3299
Open Access | Times Cited: 1
Panqin Ma, Zheng Luo, Qi Wang, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3282-3299
Open Access | Times Cited: 1
Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy
Jun Chen, Taige Zhao, Wen-bin Hong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5493-5504
Open Access | Times Cited: 1
Jun Chen, Taige Zhao, Wen-bin Hong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5493-5504
Open Access | Times Cited: 1
An ionic liquid-based delivery system of small interfering RNA targeting Bcl-2 for melanoma therapy
Yuyuan Xing, Yanhui Hu, Hongyan Wang, et al.
Biomaterials Science (2024)
Closed Access
Yuyuan Xing, Yanhui Hu, Hongyan Wang, et al.
Biomaterials Science (2024)
Closed Access
Hybrid Polydimethylsiloxane (PDMS) Incorporated Thermogelling System for Effective Liver Cancer Treatment
Panqin Ma, Lu Jiang, Xi Luo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 1
Panqin Ma, Lu Jiang, Xi Luo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 1
Efficient Sequential Delivery Nanosystem of Betulinic Acid and Celastrol for Inhibition of Tumor- Associated Fibroblast-Induced Resistance and Metastasis
Chunhong Li, Zhen Wang, Yifeng Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Chunhong Li, Zhen Wang, Yifeng Zhang, et al.
Research Square (Research Square) (2023)
Open Access
